$ATVK Balance Sheet | Understand Stock

$ATVK

$10.30 -$1.70 (14.17%) Close

$ATVK Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Unaudited consolidated balance sheets

In millions of USD, except per-share amounts

	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q1 FY2013 As of Feb 28, 2013
ASSETS
Current assets
Cash
Inventory
Accounts receivable, net
Prepaid expense
Total current assets

Long-term assets
Property and equipment, net
Total fixed assets
Franchise and Development rights, net
Commitment fees (lines of credit)
Investment in securities
Patent
Product development, net
Goodwill
Total long-term assets

Total assets
LIABILITIES AND STOCKHOLDER'S EQUITY
Current liabilities
Accounts payable
Accrued expense - estimated payroll taxes
Due to related party
Accrued interest
Secured note payable, net
Accrued interest and expenses
Short-term debt
Deferred revenue
Short-term advance from affiliates
Total current liabilities

Long-term liabilities
Security Deposit
Long term debts
Total long-term liabilities
Total liabilities
Stockholders' equity (deficit)
Preferred Stock, Value
Series A Preferred Stock
Series B Preferred Stock
Series C Preferred Stock
Series D Preferred Stock
Series E Preferred Stock
Total preferred Stock, Value

Common Stock, Value
Additional paid in capital*
(Deficit) accumulated during development stage
Common control Adjustment Account
Transfer from group entity under common control
Accumulated surplus
Total stockholders' equity

Total liabilities and stockholders' equity

Comments